Together, these trends are shaping a dynamic healthcare ecosystem, driving innovation, and optimizing patient experiences on a global scale. Each trend is, in fact, fueling the other, the combination of ever larger healthcare delivery platforms with access to almost limitless capital that are now capable of engaging in large global initiatives combined with today’s data-driven management sciences, and as was the case with retail, the re-imagining of healthcare delivery in a virtual framework is creating new limitless possibilities for access and scalability. It is not a surprise that Amazon, Walgreens, CVS, Walmart, and other large global retail corporations have all invested and continue to invest many billions of dollars to be part of this latest digital revolution.

We have seen a similar sudden emergence of “global leaders” in past industries, from retail (Wal-Mart and Amazon) to automotive (Ford & General Motors) to banking (Goldman Sachs, Bank of America, and JP Morgan). In past examples, it has been U.S. market leaders who have ultimately acted as the pioneers in building a global presence across Europe, Latin America, and the Far East. We believe a similar phenomenon is now occurring in U.S. Healthcare, such that in the next few years, the very term “U.S. healthcare” will lose its long-standing prominence in both commerce and society to be replaced with Global Healthcare, the same way that U.S. Pharma is not really the primary term when discussing the Pharma industry, but instead “Global Pharma”.